RxDoctor Payments Data

Meghan Malone, MD

Gastroenterology · Conway, SCNPI 1043395650

Payments from drug & device makers

$3,880in general payments, 2019–2025

Across 256 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Ironwood Pharmaceuticals, Inc$457
  • Merck$241
  • Johnson & Johnson$208
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$182
  • Bristol Myers Squibb$152
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,880100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,880 in reported general payments places this provider in the 55th percentile of 259 gastroenterology providers in South Carolina.

See all gastroenterology providers in South Carolina

Medicare billing

Part B allowed, 2024
$137,631
Medicare patients
663
Services billed
1,111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin21$62,046
LinzessLinaclotide30$41,144
Mesalamine41$37,896
Dexlansoprazole DrDexlansoprazole22$11,145
TrulancePlecanatide13$7,388
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates108$6,975
Mesalamine ErMesalamine15$6,156
Pantoprazole Sodium279$3,838
Omeprazole190$2,929
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine61$2,794
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl167$2,511
Dicyclomine Hcl96$2,175
SutabSod Sulf/Pot Chloride/Mag Sulf12$1,906
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C13$1,860
Sucralfate13$1,839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu$182$71,29447 claims
AbbVieLinzess$1,493$41,14430 claims
Braintree Laboratories, Inc.Sutab$58$1,90612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 259 gastroenterology providers in South Carolina.

Other gastroenterology in Conway

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →